These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36183904)

  • 1. Reversibility and therapeutic development for neurodevelopmental disorders, insights from genetic animal models.
    Megagiannis P; Suresh R; Rouleau GA; Zhou Y
    Adv Drug Deliv Rev; 2022 Dec; 191():114562. PubMed ID: 36183904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic and environmental modulation of neurodevelopmental disorders: Translational insights from labs to beds.
    Homberg JR; Kyzar EJ; Scattoni ML; Norton WH; Pittman J; Gaikwad S; Nguyen M; Poudel MK; Ullmann JF; Diamond DM; Kaluyeva AA; Parker MO; Brown RE; Song C; Gainetdinov RR; Gottesman II; Kalueff AV
    Brain Res Bull; 2016 Jul; 125():79-91. PubMed ID: 27113433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene Transfer Therapy for Neurodevelopmental Disorders.
    Ozlu C; Bailey RM; Sinnett S; Goodspeed KD
    Dev Neurosci; 2021; 43(3-4):230-240. PubMed ID: 33882495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR/dCas9 as a Therapeutic Approach for Neurodevelopmental Disorders: Innovations and Limitations Compared to Traditional Strategies.
    Ricci R; Colasante G
    Dev Neurosci; 2021; 43(3-4):253-261. PubMed ID: 33940579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transition from Animal-Based to Human Induced Pluripotent Stem Cells (iPSCs)-Based Models of Neurodevelopmental Disorders: Opportunities and Challenges.
    Guerreiro S; Maciel P
    Cells; 2023 Feb; 12(4):. PubMed ID: 36831205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulation of Neurite Outgrowth and Cell Migration in Autism and Other Neurodevelopmental Disorders.
    Prem S; Millonig JH; DiCicco-Bloom E
    Adv Neurobiol; 2020; 25():109-153. PubMed ID: 32578146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dawn of non-human primate models for neurodevelopmental disorders.
    Aida T; Feng G
    Curr Opin Genet Dev; 2020 Dec; 65():160-168. PubMed ID: 32693220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-derived iPSC modeling of rare neurodevelopmental disorders: Molecular pathophysiology and prospective therapies.
    Sabitha KR; Shetty AK; Upadhya D
    Neurosci Biobehav Rev; 2021 Feb; 121():201-219. PubMed ID: 33370574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.
    Wang HX; Li M; Lee CM; Chakraborty S; Kim HW; Bao G; Leong KW
    Chem Rev; 2017 Aug; 117(15):9874-9906. PubMed ID: 28640612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving treatment of neurodevelopmental disorders: recommendations based on preclinical studies.
    Homberg JR; Kyzar EJ; Stewart AM; Nguyen M; Poudel MK; Echevarria DJ; Collier AD; Gaikwad S; Klimenko VM; Norton W; Pittman J; Nakamura S; Koshiba M; Yamanouchi H; Apryatin SA; Scattoni ML; Diamond DM; Ullmann JF; Parker MO; Brown RE; Song C; Kalueff AV
    Expert Opin Drug Discov; 2016; 11(1):11-25. PubMed ID: 26558752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rodent genetic models of neurodevelopmental disorders and epilepsy.
    Gonzalez-Sulser A
    Eur J Paediatr Neurol; 2020 Jan; 24():66-69. PubMed ID: 31870697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges and opportunities for precision medicine in neurodevelopmental disorders.
    Chen GT; Geschwind DH
    Adv Drug Deliv Rev; 2022 Dec; 191():114564. PubMed ID: 36183905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rare deleterious mutations of HNRNP genes result in shared neurodevelopmental disorders.
    Gillentine MA; Wang T; Hoekzema K; Rosenfeld J; Liu P; Guo H; Kim CN; De Vries BBA; Vissers LELM; Nordenskjold M; Kvarnung M; Lindstrand A; Nordgren A; Gecz J; Iascone M; Cereda A; Scatigno A; Maitz S; Zanni G; Bertini E; Zweier C; Schuhmann S; Wiesener A; Pepper M; Panjwani H; Torti E; Abid F; Anselm I; Srivastava S; Atwal P; Bacino CA; Bhat G; Cobian K; Bird LM; Friedman J; Wright MS; Callewaert B; Petit F; Mathieu S; Afenjar A; Christensen CK; White KM; Elpeleg O; Berger I; Espineli EJ; Fagerberg C; Brasch-Andersen C; Hansen LK; Feyma T; Hughes S; Thiffault I; Sullivan B; Yan S; Keller K; Keren B; Mignot C; Kooy F; Meuwissen M; Basinger A; Kukolich M; Philips M; Ortega L; Drummond-Borg M; Lauridsen M; Sorensen K; Lehman A; ; Lopez-Rangel E; Levy P; Lessel D; Lotze T; Madan-Khetarpal S; Sebastian J; Vento J; Vats D; Benman LM; Mckee S; Mirzaa GM; Muss C; Pappas J; Peeters H; Romano C; Elia M; Galesi O; Simon MEH; van Gassen KLI; Simpson K; Stratton R; Syed S; Thevenon J; Palafoll IV; Vitobello A; Bournez M; Faivre L; Xia K; ; Earl RK; Nowakowski T; Bernier RA; Eichler EE
    Genome Med; 2021 Apr; 13(1):63. PubMed ID: 33874999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Genome Editing and In Vivo Delivery.
    Ramirez-Phillips AC; Liu D
    AAPS J; 2021 Jun; 23(4):80. PubMed ID: 34080099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zebrafish as a Model of Neurodevelopmental Disorders.
    de Abreu MS; Genario R; Giacomini ACVV; Demin KA; Lakstygal AM; Amstislavskaya TG; Fontana BD; Parker MO; Kalueff AV
    Neuroscience; 2020 Oct; 445():3-11. PubMed ID: 31472215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenic
    Song JM; Kang M; Park DH; Park S; Lee S; Suh YH
    J Neurosci; 2021 Mar; 41(11):2344-2359. PubMed ID: 33500274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Annual research review: The (epi)genetics of neurodevelopmental disorders in the era of whole-genome sequencing--unveiling the dark matter.
    Kiser DP; Rivero O; Lesch KP
    J Child Psychol Psychiatry; 2015 Mar; 56(3):278-95. PubMed ID: 25677560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerating therapeutic development and clinical trial readiness for STXBP1 and SYNGAP1 disorders.
    Marotta N; Boland MJ; Prosser BL
    Curr Probl Pediatr Adolesc Health Care; 2024 Aug; 54(8):101576. PubMed ID: 38472035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deciphering MECP2-associated disorders: disrupted circuits and the hope for repair.
    Qiu Z
    Curr Opin Neurobiol; 2018 Feb; 48():30-36. PubMed ID: 28961504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.